×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ACHV – achieve life sciences, inc. - common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ACHV
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/9
08:30 am
achv
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer
Low
Report
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer
12/3
08:44 am
achv
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA [Yahoo! Finance]
Medium
Report
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA [Yahoo! Finance]
12/3
08:30 am
achv
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA
Low
Report
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA
11/25
08:02 am
achv
Smoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma) [Yahoo! Finance]
Medium
Report
Smoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma) [Yahoo! Finance]
11/15
05:59 am
achv
Achieve Life Sciences, Inc. (NASDAQ: ACHV) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
Medium
Report
Achieve Life Sciences, Inc. (NASDAQ: ACHV) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
11/14
08:42 am
achv
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences [Yahoo! Finance]
11/14
08:30 am
achv
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Medium
Report
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
11/14
07:21 am
achv
Achieve Life Sciences, Inc. (NASDAQ: ACHV) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $12.00 price target on the stock.
Medium
Report
Achieve Life Sciences, Inc. (NASDAQ: ACHV) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $12.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2024
04:05 pm
achv
achieve life sciences, inc. - common shares
MISS
Report
-7.4%
achieve life sciences, inc. - common shares
8/13/2024
04:01 pm
achv
achieve life sciences, inc. - common shares
MISS
Report
0.6%
achieve life sciences, inc. - common shares
5/9/2024
04:01 pm
achv
achieve life sciences, inc. - common shares
MISS
Report
1.8%
achieve life sciences, inc. - common shares
3/28/2024
04:01 pm
achv
achieve life sciences, inc. - common shares
BEAT
Report
0.8%
achieve life sciences, inc. - common shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/9
04:46 pm
achv
Form 4 ACHIEVE LIFE SCIENCES, For: Dec 06 Filed by: Xinos Jaime
Medium
Report
Form 4 ACHIEVE LIFE SCIENCES, For: Dec 06 Filed by: Xinos Jaime
12/9
04:40 pm
achv
Form 4 ACHIEVE LIFE SCIENCES, For: Dec 06 Filed by: Oki Mark K
Medium
Report
Form 4 ACHIEVE LIFE SCIENCES, For: Dec 06 Filed by: Oki Mark K
12/9
04:38 pm
achv
Form 3 ACHIEVE LIFE SCIENCES, For: Dec 05 Filed by: Oki Mark K
Medium
Report
Form 3 ACHIEVE LIFE SCIENCES, For: Dec 05 Filed by: Oki Mark K
12/9
04:23 pm
achv
Form 8-K ACHIEVE LIFE SCIENCES, For: Dec 05
Medium
Report
Form 8-K ACHIEVE LIFE SCIENCES, For: Dec 05
12/5
04:22 pm
achv
Form S-8 ACHIEVE LIFE SCIENCES,
Low
Report
Form S-8 ACHIEVE LIFE SCIENCES,
11/19
06:02 am
achv
Form EFFECT ACHIEVE LIFE SCIENCES,
Medium
Report
Form EFFECT ACHIEVE LIFE SCIENCES,
11/15
06:31 am
achv
Form EFFECT ACHIEVE LIFE SCIENCES,
Medium
Report
Form EFFECT ACHIEVE LIFE SCIENCES,
11/12
12:14 pm
achv
Form SC 13G/A ACHIEVE LIFE SCIENCES, Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G/A ACHIEVE LIFE SCIENCES, Filed by: VANGUARD GROUP INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/30
Form 8-K ACHIEVE LIFE SCIENCES, For: Apr 27
35.3%
12/9 Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program 14.3%
5/28 Form 4 ACHIEVE LIFE SCIENCES, For: May 23 Filed by: Stewart Richard Alistair 11.6%
6/11 Achieve Life Sciences Inc (NASDAQ: ACHV) had its "buy" rating re-affirmed by analysts at LADENBURG THALM/SH SH. They now have a $20.00 price target on the stock, up previously from $12.00. 9.2%
6/7 Form 3 ACHIEVE LIFE SCIENCES, For: May 30 Filed by: Armistice Capital Master Fund Ltd. 8.4%
8/12 Achieve Life Sciences Inc (NASDAQ: ACHV) was given a new $6.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock. 7.3%
7/25 Form S-1 ACHIEVE LIFE SCIENCES, 5.7%
8/8 Form EFFECT ACHIEVE LIFE SCIENCES, 5.7%
12/26 Form SC 13G ACHIEVE LIFE SCIENCES, Filed by: CVI Investments, Inc. 5.7%
12/18 Form EFFECT ACHIEVE LIFE SCIENCES, 4.4%
12/9 Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program 14.3%
5/28 Form 4 ACHIEVE LIFE SCIENCES, For: May 23 Filed by: Stewart Richard Alistair 11.6%
6/11 Achieve Life Sciences Inc (NASDAQ: ACHV) had its "buy" rating re-affirmed by analysts at LADENBURG THALM/SH SH. They now have a $20.00 price target on the stock, up previously from $12.00. 9.2%
6/7 Form 3 ACHIEVE LIFE SCIENCES, For: May 30 Filed by: Armistice Capital Master Fund Ltd. 8.4%
8/12 Achieve Life Sciences Inc (NASDAQ: ACHV) was given a new $6.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock. 7.3%
7/25 Form S-1 ACHIEVE LIFE SCIENCES, 5.7%
8/8 Form EFFECT ACHIEVE LIFE SCIENCES, 5.7%
12/26 Form SC 13G ACHIEVE LIFE SCIENCES, Filed by: CVI Investments, Inc. 5.7%
12/18 Form EFFECT ACHIEVE LIFE SCIENCES, 4.4%
TOP News Decliners
12/17
Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
-54.0%
3/13 Achieve Life Sciences EPS beats by $0.02 [Seeking Alpha] -21.8%
6/11 Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial -21.4%
11/6 Form S-1 ACHIEVE LIFE SCIENCES, -19.2%
3/12 Achieve Life Sciences Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting -16.1%
12/16 Form S-1/A ACHIEVE LIFE SCIENCES, -11.3%
12/23 Here's Why We're A Bit Worried About Achieve Life Sciences's (NASDAQ:ACHV) Cash Burn Situation [Yahoo! Finance News] -10.3%
9/30 Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study -9.6%
5/15 Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update -9.2%
2/6 Achieve Life Sciences Announces Agreement with the FreeMind Group to Assist in Securing Non-Dilutive Funding to Evaluate Cytisinicline in Vaping and e-Cigarette Users -8.6%
3/13 Achieve Life Sciences EPS beats by $0.02 [Seeking Alpha] -21.8%
6/11 Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial -21.4%
11/6 Form S-1 ACHIEVE LIFE SCIENCES, -19.2%
3/12 Achieve Life Sciences Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting -16.1%
12/16 Form S-1/A ACHIEVE LIFE SCIENCES, -11.3%
12/23 Here's Why We're A Bit Worried About Achieve Life Sciences's (NASDAQ:ACHV) Cash Burn Situation [Yahoo! Finance News] -10.3%
9/30 Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study -9.6%
5/15 Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update -9.2%
2/6 Achieve Life Sciences Announces Agreement with the FreeMind Group to Assist in Securing Non-Dilutive Funding to Evaluate Cytisinicline in Vaping and e-Cigarette Users -8.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: